DOCSLIB.ORG

CHC Disease List

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
CHC Disease List • KIF2A-related disorder, complex cortical dysplasia with other brain CHC Disease malformations, CDCBM3 • Leri-Weill dyschondrosteo sis (LWD( • Long QT syndrome (KCNQ1) ​ ​ List • Lynch Syndrome (MSH2) ​ ​ • MAP3K7 related disorder • Marfan syndrome (FBN1) Autosomal Dominant ​ ​ • Mental retardation 5 (SYNGAP1) • ADCY5-related Dyskinesia ​ ​ • Mental retardation 7 (DYRK1A) • Apert Syndrome (FGFR2). ​ ​ ​ ​ ​ ​ • Mental retardation 23 (SETD5) • Autosomal Dominant Poly cystic Kidney ​ ​ • Mental retardation 26 (AUTS2) Disease ​ ​ • Mental retardation 31 (PURA • Benign f amilial infantile seizures 2 ​ syndrome) (BFIS2) (PRRT2) ​ ​ • Mental reta rdation 46 (KCNQ5) • Catecholaminer gic polymorphic ​ • Moebius syndrome ventricular tachycardia-1 (CPVT1) • Mowat Wilson Synd rome (ZEB2) • Central Core Disease (RYR1 relate d ​ • Myotonic dystrophy 1 (DMPK) disorder) ​ ​ • Neurofibromatosis 1 • Charcot-M arie-Tooth type 1A • Osteogenesis Imperf ecta, different • Childhood-onset epileptic types (COL1A1, COL1A2 ) encephalopathy (EEOC) (CHD2) ​ ​ ​ ​ • Retinitis pigmentosa (NR2 E3) • Congenital myasthenic syndrom e ​ ​ • RET-related disorder (Hirschsprung (CMS-CHRNE) ​ ​ ​ disease) • Dravet Syndro me (SCN1A) • Rubinste in-Taybi syndrome (CREBBP • Dystonia 6 ​ and EP300) • Ehlers Dan los syndrome, hypermobility ​ • SCN2A-related disorder type ​ • Septooptic dysplasia • Ehler s Danlos syndrome, vascular type • Stickler syndrome (C OL2A1) • Familial hemiplegic migraines 1 ​ ​ • Syndactyly type 1 (CACNA1A) ​ ​ • Tuberous Sclerosi s (TSC2) • Familial tho racic aortic aneurysms and ​ ​ • White-Sutton Syndrome (POGZ gene) dissections (FTAAD, MYLK) ​ ​ ​ ​ • FOXG1 syndrome Autosomal Recessive • Hereditary breast & ovarian cancer • (BRCA1) 2-methylbuty ryl CoA dehydrogenase ​ deficiency (2MBCD) • Heredita ry hemorrhagic telangiectasia • (ENG) 3-methylcrotonyl Co A carboxylase ​ ​ deficiency (3MCC) • Hered itary melanoma-pancreatic • cancer syndrome (CDKN2A ) 21 hydroxylase def iciency (congenital ​ ​ adrenal hyperplasia (CAH) • Hereditary pancreatitis (PRSS 1) ​ ​ • Adenosine Deaminase (ADA SICD) • Hereditary paraganglioma pheochromocytoma type 1 (SDHA and deficiency ​ ​ • SDHD) Adenosine Deaminase 2 (ADA 2) ​ deficiency • HNF4A -related hyperinsulinism and • Maturity-onset diabetes of the young 1 Alpha-1 an titrypsin deficiency • (MODY1) Alpha thalassemia • Amish brittle hair syndrome • Hypertrop hic cardiomyopathy 4 • (MYBPC3) Argininosucciate lyase (ASL) deficiency ​ ​ • Beta ketothialase deficiency (BKT) • Hypotricho sis 1 • • Kabuki Syndrom e (KMT2D) Biotinidase deficiency ​ ​ • Cartilage hair hypoplasia (CHH) • Microcephalic osteodysplastic • Charcot-Marie-Tooth neuropath y type primordial dwarfism type I (MOPD1) 4A • Mitochondrial depletion syndrome 12 • CLN 6 disease; Late Infantile Neuronal (SLC25A4, ANT1) ​ ​ Ceroid Lipofuscinosis (rare form of • MYH-associated polyposis. (MUTYH) ​ Batten disease) • Non-ketotic hyperglycinemia (NKH) • Cobalamin C de fect (MMA + • Oculocutaneous albinism type 1B Homocystinuria) (Amish albinism) • Cockayne Syndro me (type B) • Phenylalanine Hy droxylase (PAH) • Combined oxidative phospho rylation deficiency (PKU) deficiency-13 (COXPD13) (PNPT1) • PMRED-SNIP1 ​ ​ • Cortical dysplasia and focal epilepsy • Pontocerebella r hypoplasia type 1 syndrome (CNTNAP2) (EXOSC3) ​ ​ ​ ​ • Crigler-Najjar syndrom e type 1 • Primary a utosome recessive • Cystic Fibrosis microcephaly-6 (MCPH)/Seckel • Dubin Johnson Syndrome syndrome 4 • Galactosemia (Classical and Duarte • Primary Ciliary Dyskinesia (HYDIN) ​ ​ variant) • Propionic acidemia (PCCB) ​ ​ • Galloway Mowat Syndrome (Yoder • RAG-1 Severe Combined ​ Dystonia) Immunodeficiency (SCID) • Gitelman syndrome • Retinitis. Pigmentosa 49 (CNGA1) ​ ​ • Glutaric aciduria 1 (GA 1) • RSRC1-related disorder ​ • Glutaric aciduria 2 (GA 2) • Sanfilippo syndrome typ e B (MPS III B – • GM3 synthase deficiency NAGLU) ​ • Friedreich Ataxia • Short ch ain acyl CoA dehydrogenase • Hemochromatosis deficiency (SCADD) • Hereditary spastic paraplegia 20 • Short Rib Thoracic D ysplasia type 4 (SPG20), Troyer Syndrome (TTC21B) ​ • Hereditary spastic paraplegia 21 • Sitosterolemia (ABCG8 ) ​ ​ (SPG21), Mast Syndrome • SMC5-related disorder (m icrocephalic • Hereditary spastic paraple gia 45 dwarfism) (NT5C2) • Spastic Ataxia 4 (MTPAP) ​ ​ • Hypomy elinating leukodystrophy • Spinal muscular atrophy 1 (SMA) (GJC2) • Systemic primary carnitine deficiency ​ ​ • Isobuty ryl CoA dehydrogenase • TANGO2-related recurrent metabolic deficiency encephalomyopathic crises associated • Isovaleric A cidemia with rhabdomyolysis, cardiac • Juvenile Parkinson’s Disease arrhythmias, and neurodegeneration (ARPD-PARKN) (MECRCN). • Limb Girdle Mu scular Dystrophy type • TMCO1 defe ct 2A • Trichohepatone urodevelopmental • Limb Girdle Muscular Dystrophy type syndrome (THNS) (CCDC47) ​ ​ 2E • Tripeptidyl peptidase II (TPP2) ​ ​ • Ma ple syrup urine disease (MSUD) deficiency • Meckel Syndrome (Meckel-Gruber) • Thyroid Dyshormonogenesis 2A (TPO) ​ ​ • Medium chain acyl CoA dehydrogen ase • Ullrich Congenital Muscular Dystrophy deficiency (MCADD) (COL6A1) • Mental retardation 44 (METTL23) • Very long chain acyl CoA ​ ​ • Methylmalonic acidemia, isolated dehydrogenase deficiency (VLCADD) (MMA) • Wilson disease • Wolfram syndrome (WFS1) • 20q13.33 duplication syndrome ​ ​ • Zellweger Spectrum Disorde r - • 22q11.2 deletion syndrome Peroxisomal Biogenesis (PEX26) • Klinefelter syndrome (47, XXY) ​ ​ • Trisomy 9 (mosaic) Mitochondrial • Trisomy 13 (Patau s yndrome) • Leber H ereditary Optic Neuropathy • Trisomy 21 (Down syndrome) • Myoclonic Epilepsy with Ragged Red • Turner Syndrome (45, X) Fibers (MERRF) • Xp11.22 duplication • Xp22.32 terminal del etion (Turner-like X-linked syndrome) • • Creatine Transporter Deficiency XYY syndro me • Duchenne Muscular Dystrophy • Hemophilia B Imprinting Disorders: • MICPCH syndr ome (CASK related ​ ​ • Beckwith-Wiedemann syndrome (BWS) disorder) (IC2 methylation defect) • Ohdo Syn drome (MED12) ​ ​ ​ ​ • Russell-Silver Syndrome • Beta-propeller protein-a ssociated • UPD 6 neurodegeneration (BPAN) • Prader -Willi Syndrome (WDR45) • Oral-facia l-digital syndrome Other (central nervous system malformation, • Partial Androgen Insensitivity clinical diagnosis, cancer, etc.) syndrome (AR) • Acute disseminated ​ ​ • Steroid Sulfatas e Deficiency (X-linked encephalomyelitis (ADEM) Ichthyosis) • Acute myeloid leukemia • X-linked sy ndromic mental retardation, • Acute tic disorder Turner type (HUWE1) ​ ​ • Alcohol Related N eurodevelopmental Disorder (ARND) Chromosomal abnormalities • Addison’s disease • 1p36 deletion syndrome (mosaic) • Autism Spectrum Disorder • 1q43q44 deletion syndrome • Breast cancer • 1q43 terminal duplication sy ndrome • Breath holdin g spells • 4q partial trisomy syndrome • Carnitine deficiency • 5p, 9q, 16p duplication syndr omes • CHARGE syndrome (triple duplication) • Chronic inflammato ry Demyelinating • 6q27 microdeletion syndrome Polyneuropathy • 7p22.3 duplication • Cleft lip and/or palate • 7q11.23 microdupl ication syndrome • Cold urticaria/periodic fever • 9p terminal deletion syndrome • Congenital CMV infection • 10p 12.1 microdeletion syndrome • Congenital Hypothyroidism • 10q22.3 duplication syndrome • Recurrent Colon cancer • 10q24 deletion syndrome • Endometriosis • 10q partial trisomy syndro me (mosaic) • Fetal Alcohol S yndrome (FAS) • 14q11.2 microdeletion syndrome • Hemimegalencephaly • 15q11.2 microdeletion syndrome • • 15q11.2 triplication/duplication Hirschsprung disease (isodicentric Chr 15) • Hypoxic Ischemic Encephalopathy • 16p11.2 microdeleti on syndrome • In utero stroke • 16p13.11 microdeletion syndrom e • Jeavons Syndro me • • Klippel-Trenaunay s yndrome 18q21.32 deletion syndrome • Lissencephaly • Microcephaly + Deafness ​ • Pancreatic insufficiency • Paraganglioma • PHACE syndrom e • Polycystic kidney disease – suspected recessive inheritance • Prenatal Tobacco Exp osure (PTE) • Primary selective IgM deficiency • Renal oncocytosis • Retinitis pigmento sa • Sagittal craniosynost osis (isolated) • Schizencephaly & porencephaly • Severe prematurity • Spastic paraplegia ( unknown type/gene) • VATER synd rome • Vein of Galen arte riovenous malformation .
Load more

Recommended publications
  • Paternal Factors and Schizophrenia Risk: De Novo Mutations and Imprinting
    Paternal Factors and Schizophrenia Risk: De Novo Mutations and Imprinting by Dolores Malaspina Downloaded from https://academic.oup.com/schizophreniabulletin/article/27/3/379/1835092 by guest on 23 September 2021 Abstract (Impagnatiello et al. 1998; Kao et al. 1998), but there is no consensus that any particular gene plays a meaning- There is a strong genetic component for schizophrenia ful role in the etiology of schizophrenia (Hyman 2000). risk, but it is unclear how the illness is maintained in Some of the obstacles in genetic research in schiz- the population given the significantly reduced fertility ophrenia are those of any complex disorder, and include of those with the disorder. One possibility is that new incomplete penetrance, polygenic interaction (epista- mutations occur in schizophrenia vulnerability genes. sis), diagnostic instability, and variable expressivity. If so, then those with schizophrenia may have older Schizophrenia also does not show a clear Mendelian fathers, because advancing paternal age is the major inheritance pattern, although segregation analyses have source of new mutations in humans. This review variably supported dominant, recessive, additive, sex- describes several neurodevelopmental disorders that linked, and oligogenic inheritance (Book 1953; Slater have been associated with de novo mutations in the 1958; Garrone 1962; Elston and Campbell 1970; Slater paternal germ line and reviews data linking increased and Cowie 1971; Karlsson 1972; Stewart et al. 1980; schizophrenia risk with older fathers. Several genetic Risch 1990a, 1990fc; reviewed by Kendler and Diehl mechanisms that could explain this association are 1993). Furthermore, both nonallelic (Kaufmann et al. proposed, including paternal germ line mutations, 1998) and etiologic heterogeneity (Malaspina et al.
    [Show full text]
  • Bhagwan Moorjani, MD, FAAP, FAAN • Requires Knowledge of Normal CNS Developmental (I.E
    1/16/2012 Neuroimaging in Childhood • Neuroimaging issues are distinct from Pediatric Neuroimaging in adults Neurometabolic-degenerative disorder • Sedation/anesthesia and Epilepsy • Motion artifacts Bhagwan Moorjani, MD, FAAP, FAAN • Requires knowledge of normal CNS developmental (i.e. myelin maturation) • Contrast media • Parental anxiety Diagnostic Approach Neuroimaging in Epilepsy • Age of onset • Peak incidence in childhood • Static vs Progressive • Occurs as a co-morbid condition in many – Look for treatable causes pediatric disorders (birth injury, – Do not overlook abuse, Manchausen if all is negative dysmorphism, chromosomal anomalies, • Phenotype presence (syndromic, HC, NCS, developmental delays/regression) systemic involvement) • Predominant symptom (epilepsy, DD, • Many neurologic disorders in children weakness/motor, psychomotor regression, have the same chief complaint cognitive/dementia) 1 1/16/2012 Congenital Malformation • Characterized by their anatomic features • Broad categories: based on embryogenesis – Stage 1: Dorsal Induction: Formation and closure of the neural tube. (Weeks 3-4) – Stage 2: Ventral Induction: Formation of the brain segments and face. (Weeks 5-10) – Stage 3: Migration and Histogenesis: (Months 2-5) – Stage 4: Myelination: (5-15 months; matures by 3 years) Dandy Walker Malformation Dandy walker • Criteria: – high position of tentorium – dysgenesis/agenesis of vermis – cystic dilatation of fourth ventricle • commonly associated features: – hypoplasia of cerebellum – scalloping of inner table of occipital bone • associated abnormalities: – hydrocephalus 75% – dysgenesis of corpus callosum 25% – heterotropia 10% 2 1/16/2012 Etiology of Epilepsy: Developmental and Genetic Classification of Gray Matter Heterotropia Cortical Dysplasia 1. Secondary to abnormal neuronal and • displaced masses of nerve cells • Subependymal glial proliferation/apoptosis (gray matter) heterotropia (most • most common: small nest common) 2.
    [Show full text]
  • Program Nr: 1 from the 2004 ASHG Annual Meeting Mutations in A
    Program Nr: 1 from the 2004 ASHG Annual Meeting Mutations in a novel member of the chromodomain gene family cause CHARGE syndrome. L.E.L.M. Vissers1, C.M.A. van Ravenswaaij1, R. Admiraal2, J.A. Hurst3, B.B.A. de Vries1, I.M. Janssen1, W.A. van der Vliet1, E.H.L.P.G. Huys1, P.J. de Jong4, B.C.J. Hamel1, E.F.P.M. Schoenmakers1, H.G. Brunner1, A. Geurts van Kessel1, J.A. Veltman1. 1) Dept Human Genetics, UMC Nijmegen, Nijmegen, Netherlands; 2) Dept Otorhinolaryngology, UMC Nijmegen, Nijmegen, Netherlands; 3) Dept Clinical Genetics, The Churchill Hospital, Oxford, United Kingdom; 4) Children's Hospital Oakland Research Institute, BACPAC Resources, Oakland, CA. CHARGE association denotes the non-random occurrence of ocular coloboma, heart defects, choanal atresia, retarded growth and development, genital hypoplasia, ear anomalies and deafness (OMIM #214800). Almost all patients with CHARGE association are sporadic and its cause was unknown. We and others hypothesized that CHARGE association is due to a genomic microdeletion or to a mutation in a gene affecting early embryonic development. In this study array- based comparative genomic hybridization (array CGH) was used to screen patients with CHARGE association for submicroscopic DNA copy number alterations. De novo overlapping microdeletions in 8q12 were identified in two patients on a genome-wide 1 Mb resolution BAC array. A 2.3 Mb region of deletion overlap was defined using a tiling resolution chromosome 8 microarray. Sequence analysis of genes residing within this critical region revealed mutations in the CHD7 gene in 10 of the 17 CHARGE patients without microdeletions, including 7 heterozygous stop-codon mutations.
    [Show full text]
  • Mutation in Genes FBN1, AKT1, and LMNA: Marfan Syndrome, Proteus Syndrome, and Progeria Share Common Systemic Involvement
    Review Mutation in Genes FBN1, AKT1, and LMNA: Marfan Syndrome, Proteus Syndrome, and Progeria Share Common Systemic Involvement Tonmoy Biswas.1 Abstract Genetic mutations are becoming more deleterious day by day. Mutations of Genes named FBN1, AKT1, LMNA result specific protein malfunction that in turn commonly cause Marfan syndrome, Proteus syndrome, and Progeria, respectively. Articles about these conditions have been reviewed in PubMed and Google scholar with a view to finding relevant clinical features. Precise keywords have been used in search for systemic involvement of FBN1, AKT1, and LMNA gene mutations. It has been found that Marfan syndrome, Proteus syndrome, and Progeria commonly affected musculo-skeletal system, cardiovascular system, eye, and nervous system. Not only all of them shared identical systemic involvement, but also caused several very specific anomalies in various parts of the body. In spite of having some individual signs and symptoms, the mutual manifestations were worth mentio- ning. Moreover, all the features of the mutations of all three responsible genes had been co-related and systemically mentioned in this review. There can be some mutual properties of the genes FBN1, AKT1, and LMNA or in their corresponding proteins that result in the same presentations. This study may progress vision of knowledge regarding risk factors, patho-physiology, and management of these conditions, and relation to other mutations. Keywords: Genetic mutation; Marfan syndrome; Proteus syndrome; Progeria; Gene FBN1; Gene AKT1; Gene LMNA; Musculo-skeletal system; Cardiovascular system; Eye; Nervous system (Source: MeSH, NLM). Introduction Records in human mutation databases are increasing day by 5 About the author: Tonmoy The haploid human genome consists of 3 billion nucleotides day.
    [Show full text]
  • Advances in Understanding the Genetics of Syndromes Involving Congenital Upper Limb Anomalies
    Review Article Page 1 of 10 Advances in understanding the genetics of syndromes involving congenital upper limb anomalies Liying Sun1#, Yingzhao Huang2,3,4#, Sen Zhao2,3,4, Wenyao Zhong1, Mao Lin2,3,4, Yang Guo1, Yuehan Yin1, Nan Wu2,3,4, Zhihong Wu2,3,5, Wen Tian1 1Hand Surgery Department, Beijing Jishuitan Hospital, Beijing 100035, China; 2Beijing Key Laboratory for Genetic Research of Skeletal Deformity, Beijing 100730, China; 3Medical Research Center of Orthopedics, Chinese Academy of Medical Sciences, Beijing 100730, China; 4Department of Orthopedic Surgery, 5Department of Central Laboratory, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing 100730, China Contributions: (I) Conception and design: W Tian, N Wu, Z Wu, S Zhong; (II) Administrative support: All authors; (III) Provision of study materials or patients: All authors; (IV) Collection and assembly of data: Y Huang; (V) Data analysis and interpretation: L Sun; (VI) Manuscript writing: All authors; (VII) Final approval of manuscript: All authors. Correspondence to: Wen Tian. Hand Surgery Department, Beijing Jishuitan Hospital, Beijing 100035, China. Email: [email protected]. Abstract: Congenital upper limb anomalies (CULA) are a common birth defect and a significant portion of complicated syndromic anomalies have upper limb involvement. Mostly the mortality of babies with CULA can be attributed to associated anomalies. The cause of the majority of syndromic CULA was unknown until recently. Advances in genetic and genomic technologies have unraveled the genetic basis of many syndromes- associated CULA, while at the same time highlighting the extreme heterogeneity in CULA genetics. Discoveries regarding biological pathways and syndromic CULA provide insights into the limb development and bring a better understanding of the pathogenesis of CULA.
    [Show full text]
  • Circle Applicable Codes
    IDENTIFYING INFORMATION (please print legibly) Individual’s Name: DOB: Last 4 Digits of Social Security #: CIRCLE APPLICABLE CODES ICD-10 ICD-10 ICD-9 DIAGNOSTIC ICD-9 DIAGNOSTIC PRIMARY ICD-9 CODES CODE CODE PRIMARY ICD-9 CODES CODE CODE Abetalipoproteinemia 272.5 E78.6 Hallervorden-Spatz Syndrome 333.0 G23.0 Acrocephalosyndactyly (Apert’s Syndrome) 755.55 Q87.0 Head Injury, unspecified – Age of onset: 959.01 S09.90XA Adrenaleukodystrophy 277.86 E71.529 Hemiplegia, unspecified 342.9 G81.90 Arginase Deficiency 270.6 E72.21 Holoprosencephaly 742.2 Q04.2 Agenesis of the Corpus Callosum 742.2 Q04.3 Homocystinuria 270.4 E72.11 Agenesis of Septum Pellucidum 742.2 Q04.3 Huntington’s Chorea 333.4 G10 Argyria/Pachygyria/Microgyria 742.2 Q04.3 Hurler’s Syndrome 277.5 E76.01 or 758.33 Aicardi Syndrome 333 G23.8 Hyperammonemia Syndrome 270.6 E72.4 Alcohol Embryo and Fetopathy 760.71 F84.5 I-Cell Disease 272.2 E77.0 Anencephaly 655.0 Q00.0 Idiopathic Torsion Dystonia 333.6 G24.1 Angelman Syndrome 759.89 Q93.5 Incontinentia Pigmenti 757.33 Q82.3 Asperger Syndrome 299.8 F84.5 Infantile Cerebral Palsy, unspecified 343.9 G80.9 Ataxia-Telangiectasia 334.8 G11.3 Intractable Seizure Disorder 345.1 G40.309 Autistic Disorder (Childhood Autism, Infantile 299.0 F84.0 Klinefelter’s Syndrome 758.7 Q98.4 Psychosis, Kanner’s Syndrome) Biotinidase Deficiency 277.6 D84.1 Krabbe Disease 333.0 E75.23 Canavan Disease 330.0 E75.29 Kugelberg-Welander Disease 335.11 G12.1 Carpenter Syndrome 759.89 Q87.0 Larsen’s Syndrome 755.8 Q74.8 Cerebral Palsy, unspecified 343.69 G80.9
    [Show full text]
  • 2018 Etiologies by Frequencies
    2018 Etiologies in Order of Frequency by Category Hereditary Syndromes and Disorders Count CHARGE Syndrome 958 Down syndrome (Trisomy 21 syndrome) 308 Usher I syndrome 252 Stickler syndrome 130 Dandy Walker syndrome 119 Cornelia de Lange 102 Goldenhar syndrome 98 Usher II syndrome 83 Wolf-Hirschhorn syndrome (Trisomy 4p) 68 Trisomy 13 (Trisomy 13-15, Patau syndrome) 60 Pierre-Robin syndrome 57 Moebius syndrome 55 Trisomy 18 (Edwards syndrome) 52 Norrie disease 38 Leber congenital amaurosis 35 Chromosome 18, Ring 18 31 Aicardi syndrome 29 Alstrom syndrome 27 Pfieffer syndrome 27 Treacher Collins syndrome 27 Waardenburg syndrome 27 Marshall syndrome 25 Refsum syndrome 21 Cri du chat syndrome (Chromosome 5p- synd) 16 Bardet-Biedl syndrome (Laurence Moon-Biedl) 15 Hurler syndrome (MPS I-H) 15 Crouzon syndrome (Craniofacial Dysotosis) 13 NF1 - Neurofibromatosis (von Recklinghausen dis) 13 Kniest Dysplasia 12 Turner syndrome 11 Usher III syndrome 10 Cockayne syndrome 9 Apert syndrome/Acrocephalosyndactyly, Type 1 8 Leigh Disease 8 Alport syndrome 6 Monosomy 10p 6 NF2 - Bilateral Acoustic Neurofibromatosis 6 Batten disease 5 Kearns-Sayre syndrome 5 Klippel-Feil sequence 5 Hereditary Syndromes and Disorders Count Prader-Willi 5 Sturge-Weber syndrome 5 Marfan syndrome 3 Hand-Schuller-Christian (Histiocytosis X) 2 Hunter Syndrome (MPS II) 2 Maroteaux-Lamy syndrome (MPS VI) 2 Morquio syndrome (MPS IV-B) 2 Optico-Cochleo-Dentate Degeneration 2 Smith-Lemli-Opitz (SLO) syndrome 2 Wildervanck syndrome 2 Herpes-Zoster (or Hunt) 1 Vogt-Koyanagi-Harada
    [Show full text]
  • Megalencephaly and Macrocephaly
    277 Megalencephaly and Macrocephaly KellenD.Winden,MD,PhD1 Christopher J. Yuskaitis, MD, PhD1 Annapurna Poduri, MD, MPH2 1 Department of Neurology, Boston Children’s Hospital, Boston, Address for correspondence Annapurna Poduri, Epilepsy Genetics Massachusetts Program, Division of Epilepsy and Clinical Electrophysiology, 2 Epilepsy Genetics Program, Division of Epilepsy and Clinical Department of Neurology, Fegan 9, Boston Children’s Hospital, 300 Electrophysiology, Department of Neurology, Boston Children’s Longwood Avenue, Boston, MA 02115 Hospital, Boston, Massachusetts (e-mail: [email protected]). Semin Neurol 2015;35:277–287. Abstract Megalencephaly is a developmental disorder characterized by brain overgrowth secondary to increased size and/or numbers of neurons and glia. These disorders can be divided into metabolic and developmental categories based on their molecular etiologies. Metabolic megalencephalies are mostly caused by genetic defects in cellular metabolism, whereas developmental megalencephalies have recently been shown to be caused by alterations in signaling pathways that regulate neuronal replication, growth, and migration. These disorders often lead to epilepsy, developmental disabilities, and Keywords behavioral problems; specific disorders have associations with overgrowth or abnor- ► megalencephaly malities in other tissues. The molecular underpinnings of many of these disorders are ► hemimegalencephaly now understood, providing insight into how dysregulation of critical pathways leads to ►
    [Show full text]
  • CHARGE Syndrome
    orphananesthesia Anaesthesia recommendations for CHARGE syndrome Disease name: CHARGE syndrome ICD 10: Q87.8 Synonyms: CHARGE association; Hall-Hittner syndrome Disease summary: CHARGE syndrome was initially defined as a non-random association of anomalies: - Coloboma - Heart defect - Atresia choanae (choanal atresia) - Retarded growth and development - Genital hypoplasia - Ear anomalies/deafness In 1998, an expert group defined the major (the classical 4C´s: Choanal atresia, Coloboma, Characteristic ear and Cranial nerve anomalies) and minor criteria of CHARGE syndrome [1]. In 2004, mutations in the CHD7 gene were identified as the major cause. The inheritance pattern is autosomal dominant with variable expressivity. Almost all mutations occurs de novo, but parent-to-child transmission has occasionally been reported [2]. Clinical criteria for CHARGE syndrome [1] Major criteria: • Coloboma • Choanal Atresia • Cranial nerve anomalies • Abnormalities of the inner, middle, or external ear Minor criteria: • Cardiaovascular malformations • Genital hypoplasia or delayed pubertal development • Cleft lip and/or palate • Tracheoesophageal defects • Distinctive CHARGE facies • Growth retardation • Developmental delay Occasional: • Renal anomalies: duplex system, vesicoureteric reflux • Spinal anomalies: scoliosis, osteoporosis • Hand anomalies 1 • Neck/shoulder anomalies • Immune system disorders Individuals with all four major characteristics or three major and three minor characteristics are highly likely to have CHARGE syndrome [1]. CHARGE syndrome
    [Show full text]
  • CHARGE Factsheet 3 Clinical Diagnosis and Features
    The Information Pack CHARGE for Practitioners Factsheet 3 CHARGE syndrome: major and minor medical diagnostic criteria plus later onset features DR JEREMY KIRK, MD, FRCP, FRCPCH, Consultant Paediatric Endocrinologist, Birmingham Children’s Hospital Original diagnostic criteria The initial association of coloboma and choanal atresia with other congenital abnormalities was first described by Hall and separately Hittner et al. in 1979 (Hall, 1979; Hittner et al., 1979). In 1981 there was further description and expansion of the condition (Pagon et al., 1981). It was at this stage that the acronym CHARGE (C–coloboma, H–heart disease, A–atresia choanae, R–retarded growth and retarded development and/or CNS anomalies, G–genital hypoplasia, and E–ear anomalies and/or deafness) was made. In order to make the diagnosis of CHARGE syndrome, historically four out of six of the features of the acronym needed to be fulfilled, although one should be either choanal atresia or a coloboma (Pagon et al., 1981). From association to syndrome been several attempts to refine the diagnostic criteria, Initially CHARGE was described as an association; namely by Blake et al. (1998) and Verloes (2005). Both a nonrandom collection of birth defects, rather than of these use major features which are very specific for a syndrome, which is a more recognisable pattern of CHARGE syndrome, along with other minor features. birth defects (often with a known genetic cause). With the identification of the gene CHD7 in 2004 (Vissers The criteria suggested by Blake et al. consist of four et al., 2004) it has now been renamed a syndrome, major ‘C’s: as CHD7 is mutated in at least 60% of patients with 1.
    [Show full text]
  • Kabuki Syndrome
    Kabuki syndrome Description Kabuki syndrome is a disorder that affects many parts of the body. It is characterized by distinctive facial features including arched eyebrows; long eyelashes; long openings of the eyelids (long palpebral fissures) with the lower lids turned out (everted) at the outside edges; a flat, broadened tip of the nose; and large protruding earlobes. The name of this disorder comes from the resemblance of its characteristic facial appearance to stage makeup used in traditional Japanese Kabuki theater. People with Kabuki syndrome have mild to severe developmental delay and intellectual disability. Affected individuals may also have seizures, an unusually small head size ( microcephaly), or weak muscle tone (hypotonia). Some have eye problems such as rapid, involuntary eye movements (nystagmus) or eyes that do not look in the same direction (strabismus). Other characteristic features of Kabuki syndrome include short stature and skeletal abnormalities such as abnormal side-to-side curvature of the spine (scoliosis), short fifth (pinky) fingers, or problems with the hip and knee joints. The roof of the mouth may have an abnormal opening (cleft palate) or be high and arched, and dental problems are common in affected individuals. People with Kabuki syndrome may also have fingerprints with unusual features and fleshy pads at the tips of the fingers. These prominent finger pads are called fetal finger pads because they normally occur in human fetuses; in most people they disappear before birth. A wide variety of other health problems occur in some people with Kabuki syndrome. Among the most commonly reported are heart abnormalities, frequent ear infections ( otitis media), hearing loss, and early puberty.
    [Show full text]
  • Diseases of the Digestive System (KOO-K93)
    CHAPTER XI Diseases of the digestive system (KOO-K93) Diseases of oral cavity, salivary glands and jaws (KOO-K14) lijell Diseases of pulp and periapical tissues 1m Dentofacial anomalies [including malocclusion] Excludes: hemifacial atrophy or hypertrophy (Q67.4) K07 .0 Major anomalies of jaw size Hyperplasia, hypoplasia: • mandibular • maxillary Macrognathism (mandibular)(maxillary) Micrognathism (mandibular)( maxillary) Excludes: acromegaly (E22.0) Robin's syndrome (087.07) K07 .1 Anomalies of jaw-cranial base relationship Asymmetry of jaw Prognathism (mandibular)( maxillary) Retrognathism (mandibular)(maxillary) K07.2 Anomalies of dental arch relationship Cross bite (anterior)(posterior) Dis to-occlusion Mesio-occlusion Midline deviation of dental arch Openbite (anterior )(posterior) Overbite (excessive): • deep • horizontal • vertical Overjet Posterior lingual occlusion of mandibular teeth 289 ICO-N A K07.3 Anomalies of tooth position Crowding Diastema Displacement of tooth or teeth Rotation Spacing, abnormal Transposition Impacted or embedded teeth with abnormal position of such teeth or adjacent teeth K07.4 Malocclusion, unspecified K07.5 Dentofacial functional abnormalities Abnormal jaw closure Malocclusion due to: • abnormal swallowing • mouth breathing • tongue, lip or finger habits K07.6 Temporomandibular joint disorders Costen's complex or syndrome Derangement of temporomandibular joint Snapping jaw Temporomandibular joint-pain-dysfunction syndrome Excludes: current temporomandibular joint: • dislocation (S03.0) • strain (S03.4) K07.8 Other dentofacial anomalies K07.9 Dentofacial anomaly, unspecified 1m Stomatitis and related lesions K12.0 Recurrent oral aphthae Aphthous stomatitis (major)(minor) Bednar's aphthae Periadenitis mucosa necrotica recurrens Recurrent aphthous ulcer Stomatitis herpetiformis 290 DISEASES OF THE DIGESTIVE SYSTEM Diseases of oesophagus, stomach and duodenum (K20-K31) Ill Oesophagitis Abscess of oesophagus Oesophagitis: • NOS • chemical • peptic Use additional external cause code (Chapter XX), if desired, to identify cause.
    [Show full text]